Featured Research

from universities, journals, and other organizations

Hyperthermia Plus Chemotherapy Improves Outlook For Sarcoma Patients

Date:
July 16, 2007
Source:
GSF - National Research Center for Environment and Health
Summary:
Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology in Chicago, GSF scientist Professor Dr. Rolf D. Issels presented the results of the first, randomized worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.

GSF scientist Prof. Dr Rolf D. Issels.
Credit: Ulla Baumgart

Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, which ended last week, GSF scientist Prof. Dr Rolf D. Issels presented the results of the first, randomised, worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.

The study of 341 high-risk patients with deep, local sarcomas shows a significant improvement in the response of the tumour and in the survival of those patients who were treated by means of a combination of chemotherapy and of local, deep hyperthermia, in addition to operative removal of the sarcoma. This combined therapy has been applied already to a large number of patients in advance of surgery.

The well respected study results from the Clinical Co-operation Group Hyperthermia, which has existed since 1999 between the GSF – National Research Centre for Environment and Health in Munich-Neuherberg and the Großhadern Medical Centre of the University of Munich. Their spectrum of research extends from clinical analysis of deep hyperthermia for cancer therapy up to biological research in the areas of immunobiology and cell biology. The head of the Clinical Co-operation Group Hyperthermia, Prof. Dr Rolf Issels, has been working at GSF, since the mid-80s, on the use of local, deep hyperthermia as a cancer therapy.

From the beginning, tumours of soft tissues and bones, which start from the connective tissue and are called sarcomas, were taken as examples. The scientists were especially interested – together with related biological research - in the question whether certain sarcomas could be better treated with a combination of hyperthermia and other forms of therapy.

In the course of local, deep hyperthermia, tumours are warmed to 40-44° Celsius, with, the aid of electromagnetic waves. At temperatures of 42° C, cells begin to die, on account of the heat. The combination therapy developed at GSF and the Großhadern Medical Centre exploits the fact that tumour cells are more vulnerable at 40° C to the immune system and also to radiotherapy and chemotherapy.

In the past years, the results gained in the treatment of sarcomas have encouraged the research group to apply their knowledge to other forms of tumour. At the present time, within the framework of a “part body hyperthermia” project plan, they are investigating whether the combination of chemotherapy and radiotherapy with hyperthermia leads to better treatment results in cases of colon and rectum cancers and of pancreatic carcinoma, as well. Under the guidance of GSF, a “Virtual Institute of Excellence” has been founded between the Clinical Co-operation Group Hyperthermia at the Großhadern Medical Centre and the Medical Clinic Charité Berlin, in order to promote the project plan, which will initially be sponsored for three years by the Initiative and Networking Fund of the Helmholtz Association of German Research Centres.

The Scientific – Technical Director of GSF, Prof. Dr Wess, regards this as a successful example of translational research. “The concept of research in co-operation groups together with clinical partners and the creation of clinical research platforms is an essential prerequisite for the prompt application of knowledge from fundamental research to clinical practice and vice versa.”


Story Source:

The above story is based on materials provided by GSF - National Research Center for Environment and Health. Note: Materials may be edited for content and length.


Cite This Page:

GSF - National Research Center for Environment and Health. "Hyperthermia Plus Chemotherapy Improves Outlook For Sarcoma Patients." ScienceDaily. ScienceDaily, 16 July 2007. <www.sciencedaily.com/releases/2007/07/070713131325.htm>.
GSF - National Research Center for Environment and Health. (2007, July 16). Hyperthermia Plus Chemotherapy Improves Outlook For Sarcoma Patients. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2007/07/070713131325.htm
GSF - National Research Center for Environment and Health. "Hyperthermia Plus Chemotherapy Improves Outlook For Sarcoma Patients." ScienceDaily. www.sciencedaily.com/releases/2007/07/070713131325.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) — Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) — Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Raw: Elephant Undergoes Surgery in Tbilisi Zoo

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

AP (Sep. 18, 2014) — Grand the elephant has successfully undergone surgery to remove a portion of infected tusk at Tbilisi Zoo in Georgia. British veterinary surgeons used an electric drill to extract the infected piece. (Sept. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins